Decibel Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
DBTX Nasdaq 8731 https://www.decibeltx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Decibel Therapeutics Inc

4 big deal reports: Michael Kors parent rockets on huge buyout deal with Tapestry - Aug 12th, 2023 8:43 am
Biotech Stock Roundup: SAGE, GRTX Plunge on Setback, REGN to Buy DBTX & More News - Aug 11th, 2023 2:34 pm
Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update - Aug 11th, 2023 11:45 am
Regeneron (REGN) to Buy Decibel, Gains on Hearing Loss Therapies - Aug 10th, 2023 4:03 pm
Decibel Therapeutics, Inc. (NASDAQ:DBTX) surges 80%; private equity firms who own 41% shares profited along with institutions - Aug 10th, 2023 10:05 am
Regeneron to buy Boston-based hearing loss biotech for $213M - Aug 9th, 2023 5:56 pm
Decibel Therapeutics Shares Soar on Acquisition by Regeneron Pharmaceuticals - Aug 9th, 2023 4:29 pm
Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs - Aug 9th, 2023 11:30 am
Will Decibel Therapeutics (NASDAQ:DBTX) Spend Its Cash Wisely? - Jun 29th, 2023 5:48 pm
Decibel Therapeutics to Participate in the Upcoming Jefferies Healthcare Conference - Jun 2nd, 2023 11:00 am
Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting - Jun 1st, 2023 8:30 pm
Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy Summit - May 17th, 2023 8:30 pm
Decibel Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update - May 15th, 2023 11:45 am
Decibel Therapeutics Announces Approval of Clinical Trial Application by the Spanish Agency of Medicines and Medical Devices (AEMPS) to Initiate Clinical Development of Lead Gene Therapy Candidate DB-OTO - May 12th, 2023 11:00 am
Decibel Therapeutics to Present at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting - May 10th, 2023 8:30 pm
Decibel Therapeutics Receives European Orphan Drug Designation for Lead Gene Therapy Candidate DB-OTO - Mar 30th, 2023 11:00 am
Decibel Therapeutics to Participate in the Upcoming Guggenheim Healthcare Talks | Genomic Medicines and Rare Disease Days - Mar 28th, 2023 8:30 pm
Decibel Therapeutics Appoints Matthew Kapusta to its Board of Directors - Mar 21st, 2023 11:00 am
Decibel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update - Mar 14th, 2023 8:05 pm
private equity firms who own 39% along with institutions invested in Decibel Therapeutics, Inc. (NASDAQ:DBTX) saw increase in their holdings value last week - Mar 2nd, 2023 10:52 am